What exactly is Retatrutide, and where does the 30mg tier fit?
Retatrutide is a triple-agonist synthetic peptide at the GLP-1, GIP, and glucagon receptors, studied in pre-clinical metabolic-axis models. The 30mg per vial tier is the intermediate high-mass step, sitting between mid-cohort (RT20) and high-throughput (RT40+) presentations. All six tiers on the ladder (5, 10, 20, 30, 40, 60 mg) ship as kits of 10 vials or single vials.
What does this specific lot’s CoA cover?
Every RT30-30MG-10V lot ships with a batch-specific certificate: reverse-phase HPLC purity by area and mass-spec identity against theoretical mass. The CoA is not a stability panel — those are separate assays we do not run in-house.
How do I reconstitute a 30mg Retatrutide vial?
- Wipe the vial stopper with an alcohol swab.
- Draw 2 to 4 mL of bacteriostatic water (target working concentration determines exact volume).
- Inject the diluent slowly against the vial wall — do not aim at the peptide cake.
- Swirl gently to dissolve. Do not shake.
- Store the reconstituted vial at 2 to 8 °C. Use within 30 days.
Should I order the 30mg tier, or a different size?
Intermediate high-mass tier. Sits between mid-cohort (RT20) and high-throughput (RT40+). Useful when a study design needs headroom for concentration adjustments mid-run.
How is Retatrutide different from Tirzepatide?
Tirzepatide is a dual GLP-1 / GIP agonist. Retatrutide adds a third arm at the glucagon receptor. The pre-clinical metabolic-axis literature treats that third activity as the mechanistic distinction between the two molecules.
What ships in the box, and how fast?
- 10 lyophilized Retatrutide 30mg vials
- 1 lot-specific certificate of analysis (HPLC + MS)
- 1 handling and reconstitution insert
Orders placed before 14:00 PT ship the same business day from our British Columbia facility. Canadian orders arrive in 2 to 4 business days after dispatch.
